Clinical practice guidelines for the diagnosis and treatment of certain types of cancer are surprisingly unstandardized.
Improved patient access to medications and fewer patent expirations will result in a 30% increase in global drug spending, to $1.3 trillion, over the next 5 years.
Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.
A former pharmacy technician thought the prescription pill records she was finagling were better shred than read.
Expanding upon efforts to implement the federal Drug Quality and Security Act enacted 1 year ago, the FDA today released 3 policy documents that assist companies that compound sterile drugs with registering as outsourcing facilities.
Based on patient response rates and efficacy, olanzapine/fluoxetine is the ideal first-line treatment for depression caused by bipolar disorder.
Forever Beautiful Bee Pollen and Forever Beautiful Infinity were found to be forever dangerous to consumers.